|
Market Closed -
Euronext Paris
12:55:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.8400 EUR | +0.72% |
|
+2.44% | +40.94% |
| 10-26 | Biosynex US Unit Bags $6 Million Award for DPP Biothreat Panel Assay Development | MT |
| 10-23 | A Biosynex subsidiary secures $5.7m in financing |
Business description: Biosynex

- manufacturing of diagnosis tests for own account;
- sale of diagnosis tests supplied by other manufacturers of semi-finished products;
- research and development services for third party;
- sale of licenses;
- sale of biological reagents.
Number of employees: 397
Sales by Activity: Biosynex
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Sale of Merchandise | 175M | 99.36M | 52.09M | 42.94M | 39.47M |
Products Sold | 44.06M | 29.86M | 15.39M | 24.63M | 25.21M |
Services Sold | 18.58M | 9.39M | 2.37M | 1.89M | 1.52M |
Unallocated Immobilised Production | 525K | 672K | 1.35M | 911K | 528K |
Unallocated Operating Grants | 436K | 282K | - | - | - |
Geographical breakdown of sales: Biosynex
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
France | 194M | 120M | 52.5M | 52.82M | 49.26M |
Export | 189M | 76.4M | 40.4M | 48.35M | 45.93M |
Executive Committee: Biosynex
| Manager | Title | Age | Since |
|---|---|---|---|
Larry Abensur
CEO | Chief Executive Officer | 71 | 2015-06-23 |
Thierry Paper
CTO | Chief Tech/Sci/R&D Officer | 63 | 2014-12-31 |
Oren Bitton
PRN | Corporate Officer/Principal | - | - |
Composition of the Board of Directors: Biosynex
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Paper
BRD | Director/Board Member | 63 | 2015-06-23 |
Thomas Lamy
BRD | Director/Board Member | - | 2015-06-23 |
Larry Abensur
CHM | Chairman | 71 | 2015-06-23 |
Elie Fraenckel
BRD | Director/Board Member | - | 2012-10-31 |
Brigitte Geny
BRD | Director/Board Member | - | 2024-06-06 |
Diane Abensur
BRD | Director/Board Member | - | 2024-06-06 |
Company details: Biosynex
Biosynex SA
22, boulevard Sebastien Brant
67400, Illkirch-Graffenstaden
+33 3 88 78 78 87
http://www.biosynex.com
Group companies: Biosynex
| Name | Category and Sector |
|---|---|
Biosynex Swiss SA |
Diagnostic & Testing Substances
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.72% | +2.44% | +30.43% | -90.12% | 17.13M | ||
| -0.45% | +0.19% | -19.30% | +10.54% | 178B | ||
| +0.86% | -0.13% | -20.78% | +16.07% | 116B | ||
| +0.88% | +0.16% | +0.69% | +36.51% | 115B | ||
| -2.26% | +18.07% | -43.85% | +5.76% | 93.1B | ||
| -0.31% | -5.51% | -3.48% | +72.86% | 62.09B | ||
| +0.17% | +1.64% | +8.50% | +82.24% | 55.87B | ||
| +0.07% | +0.70% | +4.34% | -22.43% | 53.12B | ||
| +0.30% | +0.89% | -13.05% | +43.83% | 44.22B | ||
| +0.10% | +3.37% | -4.73% | -8.71% | 33.59B | ||
| Average | +0.14% | +2.22% | -6.12% | +14.65% | 75.1B | |
| Weighted average by Cap. | +0.18% | +2.37% | -13.44% | +24.03% |
- Stock Market
- Stocks
- ALBIO Stock
- Company Biosynex
Select your edition
All financial news and data tailored to specific country editions

















